ReviewTherapeutic advances in gastroenterology2025
Body surface gastric mapping facilitates the management of pediatric disorders of gut-brain interaction.
Review in Therapeutic advances in gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Body Surface Gastric Mapping Improves Diagnosis of Gastric Motility Disorders.Current gastroenterology reports · 2026Review
- Body Surface Gastric Mapping (BSGM): Is This the Future Standard of Care Noninvasive Test for Gastric Symptoms in Pediatrics?Neurogastroenterology and motility · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Disorders of gut-brain interaction (DGBI) are among the commonest contributors to disease burden in children, yet remain difficult to diagnose and treat, in part because available tests inadequately capture underlying mechanisms or link physiology to symptoms. Body surface gastric mapping (BSGM) is a next-generation, noninvasive electrophysiological technology that records high-resolution gastric slow-wave activity with simultaneous symptom logging. This review summarizes emerging evidence that BSGM may fill a key diagnostic gap in pediatric DGBI. After outlining the burden and multifactorial pathophysiology of pediatric DGBI, we compare alternative investigations-including electrogastrography, gastric emptying scintigraphy, and antroduodenal manometry-and highlight their limitations in pediatrics, including regarding reproducibility, accessibility, invasiveness, and symptom correlation. We then describe BSGM methodology, validated spectral metrics, symptom integration, and standardized testing protocols. Early pediatric studies have demonstrated excellent feasibility, particularly in adolescents, established preliminary normative ranges, and identified phenotypes to distinguish neuromuscular disorders, delayed meal responses, and alternative symptom profiles to help inform targeted care. Concordance with antroduodenal manometry is also discussed. Finally, we outline research priorities, including the need for larger multicenter cohort studies, formalization of pediatric-specific reference intervals, and longitudinal studies assessing treatment responses. BSGM shows potential as a valuable noninvasive diagnostic tool for better characterizing pediatric DGBIs, though further validation is required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.